Major bleeding and thrombosis at the time of diagnosis and during follow-up
. | At time of diagnosis . | During follow-up . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
All patients (n = 101) . | Propositi (n = 67) . | Relatives (n = 34) . | All patients (n = 101) . | Propositi (n = 67) . | Relatives (n = 34) . | |||||||
No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | |
Major bleeding | 11 | 10.9 | 9 | 13.4 | 2 | 5.9 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Critical area* | 3 | 3.0 | 3 | 4.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Requiring blood or fibrinogen transfusion | 6 | 5.9 | 4 | 6.0 | 2 | 5.9 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Requiring surgery intervention | 2 | 2.0 | 2 | 3.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total thrombosis† | 14 | 13.9 | 11 | 16.4 | 3 | 8.8 | 14 | 13.8 | 11 | 16.4 | 3 | 12.5 |
Venous thrombosis | 10 | 9.9 | 7 | 10.5 | 3 | 8.8 | 11 | 10.9 | 9 | 13.4 | 2 | 5.9 |
Deep venous thrombosis | 8 | 7.9 | 6 | 9.0 | 2 | 5.9 | 3 | 3.0 | 2 | 3.0 | 1 | 2.9 |
Provoked | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2.0 | 1 | 1.6 | 1 | 2.9 |
Recurrent | 3 | 3.0 | 2 | 3.0 | 1 | 3.0 | 1 | 1.0 | 0 | 0 | 1 | 2.9 |
PE | 2 | 2.0 | 1 | 1.5 | 1 | 2.9 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Provoked | 1 | 1.0 | 1 | 1.5 | 0 | 0 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Superficial thrombophlebitis | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Other‡ | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4.0 | 3 | 4.5 | 1 | 2.9 |
Recurrent | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.0 | 1 | 1.6 | 0 | 0 |
Arterial thrombosis | 4 | 4.0 | 4 | 6.0 | 0 | 0 | 6 | 5.9 | 4 | 6.4 | 2 | 5.9 |
Stroke | 3 | 3.0 | 3 | 4.5 | 0 | 0 | 2 | 2.0 | 1 | 1.6 | 1 | 2.9 |
Acute myocardial infarction | 1 | 1.0 | 1 | 1.5 | 0 | 0 | 2 | 2.0 | 1 | 1.6 | 1 | 2.9 |
Recurrent | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2.0 | 1 | 1.6 | 1 | 2.9 |
Peripheral thrombosis | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.0 | 1 | 1.6 | 0 | 0 |
Recurrent | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.0 | 1 | 1.6 | 0 | 0 |
Other§ | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.0 | 1 | 1.6 | 0 | 0 |
. | At time of diagnosis . | During follow-up . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
All patients (n = 101) . | Propositi (n = 67) . | Relatives (n = 34) . | All patients (n = 101) . | Propositi (n = 67) . | Relatives (n = 34) . | |||||||
No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | |
Major bleeding | 11 | 10.9 | 9 | 13.4 | 2 | 5.9 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Critical area* | 3 | 3.0 | 3 | 4.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Requiring blood or fibrinogen transfusion | 6 | 5.9 | 4 | 6.0 | 2 | 5.9 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Requiring surgery intervention | 2 | 2.0 | 2 | 3.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total thrombosis† | 14 | 13.9 | 11 | 16.4 | 3 | 8.8 | 14 | 13.8 | 11 | 16.4 | 3 | 12.5 |
Venous thrombosis | 10 | 9.9 | 7 | 10.5 | 3 | 8.8 | 11 | 10.9 | 9 | 13.4 | 2 | 5.9 |
Deep venous thrombosis | 8 | 7.9 | 6 | 9.0 | 2 | 5.9 | 3 | 3.0 | 2 | 3.0 | 1 | 2.9 |
Provoked | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2.0 | 1 | 1.6 | 1 | 2.9 |
Recurrent | 3 | 3.0 | 2 | 3.0 | 1 | 3.0 | 1 | 1.0 | 0 | 0 | 1 | 2.9 |
PE | 2 | 2.0 | 1 | 1.5 | 1 | 2.9 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Provoked | 1 | 1.0 | 1 | 1.5 | 0 | 0 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Superficial thrombophlebitis | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2.0 | 2 | 3.0 | 0 | 0 |
Other‡ | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4.0 | 3 | 4.5 | 1 | 2.9 |
Recurrent | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.0 | 1 | 1.6 | 0 | 0 |
Arterial thrombosis | 4 | 4.0 | 4 | 6.0 | 0 | 0 | 6 | 5.9 | 4 | 6.4 | 2 | 5.9 |
Stroke | 3 | 3.0 | 3 | 4.5 | 0 | 0 | 2 | 2.0 | 1 | 1.6 | 1 | 2.9 |
Acute myocardial infarction | 1 | 1.0 | 1 | 1.5 | 0 | 0 | 2 | 2.0 | 1 | 1.6 | 1 | 2.9 |
Recurrent | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2.0 | 1 | 1.6 | 1 | 2.9 |
Peripheral thrombosis | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.0 | 1 | 1.6 | 0 | 0 |
Recurrent | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.0 | 1 | 1.6 | 0 | 0 |
Other§ | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.0 | 1 | 1.6 | 0 | 0 |